Tumor lesion segmentation is one of the most important tasks in medical image analysis. In clinical practice, Fluorodeoxyglucose Positron-Emission Tomography~(FDG-PET) is a widely used technique to identify and quantify metabolically active tumors. However, since FDG-PET scans only provide metabolic information, healthy tissue or benign disease with irregular glucose consumption may be mistaken for cancer. To handle this challenge, PET is commonly combined with Computed Tomography~(CT), with the CT used to obtain the anatomic structure of the patient. The combination of PET-based metabolic and CT-based anatomic information can contribute to better tumor segmentation results. %Computed tomography~(CT) is a popular modality to illustrate the anatomic structure of the patient. The combination of PET and CT is promising to handle this challenge by utilizing metabolic and anatomic information. In this paper, we explore the potential of U-Net for lesion segmentation in whole-body FDG-PET/CT scans from three aspects, including network architecture, data preprocessing, and data augmentation. The experimental results demonstrate that the vanilla U-Net with proper input shape can achieve satisfactory performance. Specifically, our method achieves first place in both preliminary and final leaderboards of the autoPET 2022 challenge. Our code is available at https://github.com/Yejin0111/autoPET2022_Blackbean.
翻译:在临床实践中,Fluoroderoxygluose Posicron-Emission Tomagraphy~(FDG-PET)是一种广泛使用的技术,用来识别和量化代谢活性肿瘤。然而,由于FDG-PET扫描只提供代谢信息、健康组织或良性疾病,而非正常食用葡萄糖则可能被误认为癌症。为了应对这一挑战,PET通常与Computtography~(CT)结合,而CT用来获取病人的解剖结构。基于PET的代谢和基于CT的解剖学信息相结合,可以有助于更好的肿瘤分解结果。%Computed tomagraphic ~(CT)只是用来说明病人的解剖结构的流行模式。将http://ET和CT结合起来,有可能通过使用代谢和解剖信息来应对这一挑战。在本文中,我们探索了在全组织 FDG-PET-PET-CT-CT-CT-CT 和CT- 解析- 的解析网络的UNet 组合组合,在初步数据中可以实现我们BILARC- 的系统- 的系统化处理结果。